Abraxane and Alimta in Advanced Solid Tumors
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Lung Cancer|Unspecified Adult Solid Tumor, Protocol Specific
Interventions: DRUG: Abraxane|DRUG: Alimta
Sponsor: University of California, Davis
Collaborators: Celgene|Eli Lilly and Company